Closing fistulas in Crohn's disease - Should the accent be on maintenance or safety?

被引：18
作者：
Fiocchi, C [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 09期
关键词：
D O I：
10.1056/NEJMe048001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：934 / 936
页数：3
相关论文
共 15 条
[1]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[2]   Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[3]   The relationship between infliximab treatment and lymphoma in Crohn's disease [J].
Bickston, SJ ;
Lichtenstein, GR ;
Arseneau, KO ;
Cohen, RB ;
Cominelli, F .
GASTROENTEROLOGY, 1999, 117 (06) :1433-1437
[4]   The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients [J].
Colombel, JF ;
Loftus, EV ;
Tremaine, WJ ;
Egan, LJ ;
Harmsen, WS ;
Schleck, CD ;
Zinsmeister, AR ;
Sandborn, WJ .
GASTROENTEROLOGY, 2004, 126 (01) :19-31
[5]   Inflammatory bowel disease: dogmas and heresies [J].
Fiocchi, C .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (04) :306-311
[6]   Natalizumab for active Crohn's disease. [J].
Ghosh, S ;
Goldin, E ;
Gordon, FH ;
Malchow, HA ;
Rask-Madsen, J ;
Rutgeerts, P ;
Vyhnalek, P ;
Zádorová, Z ;
Palmer, T ;
Donoghue, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :24-32
[7]   Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549
[8]   Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].
Keane, J ;
Gershon, S ;
Wise, RP ;
Mirabile-Levens, E ;
Kasznica, J ;
Schwieterman, WD ;
Siegel, JN ;
Braun, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104
[9]   Treatment of fistulizing Crohn's disease [J].
Lichtenstein, GR .
GASTROENTEROLOGY, 2000, 119 (04) :1132-1147
[10]   Hyperbaric oxygen therapy for perineal Crohn's disease [J].
Noyer, CM ;
Brandt, LJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (02) :318-321
12